CENTRUM HYPERTHERMIE

Oncothermie is een effectieve ondersteuning bij kanker. Oncothermie is een vorm van elektro-hyperthermie voor oncologische behandelingen. Het is een complementaire interventie tegen verschillende soorten tumoren. In tegenstelling tot conventionele hyperthermie, bestrijdt oncothermie kanker niet alleen met warmte. De behandeling is gebaseerd op hetzelfde idee als klassieke hyperthermie, maar het doel is, naast een verhoging van de temperatuur, vooral de directe opname van elektrische veldenergie in de extracellulaire vloeistof. Deze directe opname zorgt dus voor de vernietiging van het membraan van de kankercellen. Oncothermie heeft net als andere vormen van hyperthermie een synergetisch effect op radiotherapie en verschillende soorten chemotherapieën.

HY-DEEP 600WM delivers capacitive 13.56 MHz radio waves in the area of ​​the patient's body to be treated. The radio waves are transmitted for one hour to obtain an optimal therapeutic result, strengthening the immune system and destroying the cancer cells. Treatment with HY-DEEP 600WM is simple and effective, painless, non-invasive and without side effects. Hyperthermia treatment is suitable for most cancer patients with solid tumors. Deep hyperthermia by heating in a controlled temperature range activates a series of mechanisms including cell apoptosis. Treatment improves the body's response to chemo and radio therapy when used as an adjuvant.

Hyperthermia is a therapeutic application of heat utilized to raise, in a controlled manner, the temperature of certain organs and tissues in a range between 41�C and 45�C. In oncology it is used to increase the temperature of a region of the body affected by cancer in order to contrast the progression of the tumor. Hyperthermia therapy has been developed in oncology based on the fact that, with respect to normal tissue cells, tumor cells are more sensitive to temperatures in the range between 40�C and 45�C. The efficacy of heat on tumors can be related to the peculiar combination of hypoxia, nutrient deficiency and acidosis characterizing tumor cells (Hildebrandt et al., 2002; Engin K. et al., 1996; Dewey et al., 1994; Streffer et al., 1987; Giovannella et al 1977; Strom et al., 1977). However in most cases adequate heating of the whole tumor at moderate temperature is difficult to obtain, thus hyperthermia application as a single oncologic treatment modality may be limited.